Vyluma is a startup founded in 2021, with a slogan that emphasizes their commitment to developing novel ophthalmic treatments to address global unmet needs. The company's name originates from languages across the globe, symbolizing their goal to serve a global population by providing effective pharmaceutical ophthalmic solutions. Although specific details about their industries and previous investments are not available at this time, Vyluma is based in the United States. As a potential investment opportunity, Vyluma's focus on addressing global unmet needs in ophthalmic treatments makes them a compelling prospect for venture capitalists seeking impactful healthcare solutions.
There is no investment information
No recent news or press coverage available for Vyluma.